by Cort Johnson | Oct 18, 2018 | Homepage, Metabolism
A New Approach To Chronic Fatigue Syndrome If we ask Nature a question and ask it well, Nature answers. Most of the time the answer refutes our hypothesis. This time, Nature didn’t refute the hypothesis. Robert Phair Ron Davis mentioned one of chronic fatigue... 
by Cort Johnson | Oct 13, 2018 | Cannabis, Cymbalta, Dextromethorphan, Fibromyalgia, Homepage, Low Dose Naltrexone, Lyrica, Neuroinflammation, Supplements
“Finding an objective neurochemical change in the brains of people who are used to being told that their problems are imaginary is pretty important…” Marco Loggia Jarred Younger has believed for quite some time that the glial cells in fibromyalgia... 
by Cort Johnson | Oct 3, 2018 | Autoimmune, Energy Production, Homepage, Human Herpes Virus Six (HHV-6), Immune, Neuroinflammation
As we know, grant applications in chronic fatigue syndrome (ME/CFS) are hard to come by. Freedom of Information Requests indicate that the NIH received the lowest number of ME/CFS grant applications in memory last year – just 15. Since the NIH spends MUCH more... 
by Cort Johnson | Sep 25, 2018 | Brain, Homepage, Inflammation, Neuroinflammation, Neuroinflammation, T-cells
Breaches in the Barrier The last article reported that Younger speculated that people with chronic fatigue syndrome (ME/CFS) have an immune-triggered metabolic disorder. The widespread neuroinflammation found in ME/CFS patients provides a clue, he thinks, to... 
by Cort Johnson | Sep 24, 2018 | Basal Ganglia, Brain, Energy Production, Homepage, Insula, Neuroinflammation
Neuroinflammation, Fatigue and Pain Lab Stop We were having a case of déjà vu as we drove around the surprisingly large campus. Getting into the NIH to see Avindra Nath had been a nightmare. It turned out that the NIH would only allow the big van through one access... 
by Cort Johnson | Sep 19, 2018 | Gut, Homepage, IVIG, Low Dose Naltrexone, Mast cell activation syndrome, POTS, Xifaxin
“The dramatic response to therapy in this patient is remarkable and could help others who suffer from POTS and MCAS.” The authors This, the fourth and last of a series of blogs featuring IVIG, and in this case other treatments, was sparked by attending the 2018...
